Lexicon Pharmaceuticals Inc (LXRX)

[BooDog]

Added 3.13.

[ipo_dude]

So BCDA had an offering too and it ran !! This didn’t shit

[BooDog]

I should have added that if they get FDA approval this will beat Citigroups estimate of $6 BIG TIME.

That looks likely too imo.

[BooDog]

Citigroup setting a price target of $6 was an easy tell imo that an offering was near. Their speculation without data to support it was way out there. No one knows the future. The herd simply reacted to that, probably mostly traders, but certainly some investors. Volatility came in and many took advantage.

Results will take this on up big time imo. Longs know to ignore the day to day.

Just my thoughts anyway. This manipulation runs rampant in bio land.

[joro44]

Do not understand the 3.20 at all.

Just screwed investors today big time with that announcement.

This would have run 5-8 bucks today if that was not announced or set at a better price.

[BooDog]

$65M @ 3.20. Really? Figured that'd be coming after their $6 target.

https://finance.yahoo.com/news/lexicon-announces-offering-common-stock-130200745.html

[BooDog]

Lexicon Pharmaceuticals Receives Fast Track Designation From the FDA for LX9211 for Diabetic Peripheral Neuropathic Pain

https://ih.advfn.com/stock-market/NASDAQ/lexicon-pharmaceuticals-LXRX/stock-news/83883256/lexicon-pharmaceuticals-receives-fast-track-design

Skimmed a few @ $5 but certainly looking to add again.

[BooDog]

Glad i added on the dip!!!

Bring on a deal!

[Daytrader0001]

Maybe a BUYER Company

[Guzzi62]

Thanks, looks like this will turn into a nice little money earner.

I have no idea at what price this can end at, FDA meeting in January, is between 10 & 20 realistic if all goes well?

If it keeps going up, I will likely sell off about 20% so I am covered in case of disaster.

[ClayTrader]

* * $LXRX Video Chart 12-08-2020 * *

Link to Video - click here to watch the technical chart video

[powerbattles]

Awesome day here!

[crudeoil24]

Lexicon Pharmaceuticals shares are trading higher after Citigroup upgraded the stock from Neutral to Buy and raised its price target from $2.1 to $6 per share.

LXRX

[bleu22]

This bad boy is strong...

[BooDog]

Took a few more off @ 3.21. eom

[Pt3]

when is next month

[bleu22]

They are bullish on heart failure drug caused from diabetes...

[bleu22]

FDA meeting next month, looks like they have the goods... GLTA

[joro44]

Be nice to know why they raised it. Maybe a PR will be out today. They must know something.

[BooDog]

2020-12-08 12:59:00 GMT DJ Lexicon Pharma Price Target Raised to $6.00/Share From $2.10 by Citigroup

Took a few off 2.20, looks like I may have been a bit impatient.

[Daytrader0001]

Looking Good for LONG ALERT Play

[BooDog]

Nice going Guzzi! Added myself last Friday @ 1.60.

[Guzzi62]

Gone up a lot over the last few days and pre-market looks good too.

Glad I came in at 1.5 last week.

[JohnCM]

I do not own.

[BooDog]

Agree. If this reversal sticks we could see this test the major resistance levels of $2 and possibly $3.


Charts are looking pretty good.

LXRX daily

LXRX reversal Notice the inverted head & shoulders. Big time bullish signal.

All imo of course.

[JohnCM]

$2.00 would be big.

[BooDog]

A little more momentum and the walls will be coming down!

Happy Friday!

This market is NUTS!!!

[JohnCM]

Interesting ...

[BooDog]

Kinda looks like this could see another wave up. Gap hasn't even filled yet.

LXRX 1.56

[novicetrader]

What's next for LXRX after the positive SOLOIST and SCORED peer review recently?They are in Phase 3 for Sotagliflozin,right?So,is an approval the next anticipated step?Read that they are meeting with the FDA in Jan 2021,what is that meeting related to?Thanks.

[ClayTrader]

* * $LXRX Video Chart 11-17-2020 * *

Link to Video - click here to watch the technical chart video

[bleu22]

Same here, the news and the volume are both good... GLTA

[Imott]

1.80's looks good for me to come out and play and not look back here again all day.

[Pedro2004]

I thought this would have popped to at least $3.00 today

My mistake

[Major_Bankz]

yep that's an easy reachable target with this Phase 3 news.

[BooDog]

Holding the rest of my shares for $5+.

[Major_Bankz]

Heart Attack and Stroke is the most common ailment, the MARKET for LXRX is HUGE!

[Major_Bankz]

LXRX BOOM $2.20

[Major_Bankz]

LXRX $2.04 Phase 3/ Peer Reviewed, Stroke/ Heart Attack is a HUGE Market! IMO

[BooDog]

Heading back over $2. May be one of todays runners.

[BooDog]

Nothing new in bioland that's for sure. Excellent news that makes LXRX even more attractive.

Thanks for posting, haven't had a chance to check filings yet this morning.

Sotagliflozin Significantly Reduced Total Cardiovascular Deaths, Heart Failure Hospitalization and Urgent Visits, Achieving Primary Endpoint in Both Studies


http://www.lexpharma.com/media-center/news/760-results-from-soloist-and-scored-outcomes-studies-presented-at-late-breaking-science-session-of-american-heart-association-scientific-sessions-and-published-in-the-new-england-journal-of-medicine

[BooDog]

Excellent! Peer review!

https://finance.yahoo.com/news/results-soloist-scored-outcomes-studies-030200976.html

Skimmed a few in PM.

I just can't help myself sometimes. It's been beaten into my brain to take green when it's screaming at me!

GLTA

[crudeoil24]

DILUTION > SHELF PLACEMENT > SEC 424B5 >LXRX has entered into an Open Market Sale AgreementSM (the “sales agreement”) with Jefferies LLC (“Jefferies”) relating to the shares of our common stock, par value $0.001 per share (“common stock”), offered by this prospectus supplement. In accordance with the terms of the sales agreement, we may offer and sell our common stock having an aggregate sales price of up to $50,000,000 from time to time through Jefferies acting as our sales agent.
Our common stock trades on the Nasdaq under the symbol “LXRX.” On October 29, 2020, the last reported sale price of our common stock on the Nasdaq was $1.16 per share.
Sales of common stock, if any, under this prospectus supplement will be made in sales deemed to be an “at the market offering” as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended, or the Securities Act. Jefferies is not required to sell any specific amount of securities, but will act as our sales agent using commercially reasonable efforts consistent with its normal trading and sales practices, on mutually agreed terms between Jefferies and us. There is no arrangement for funds to be received in any escrow, trust or similar arrangement.
The compensation to Jefferies for sales of common stock sold pursuant to the sales agreement will be at an amount equal to 3.0% of the gross proceeds of any shares of common stock sold under the sales agreement. The net proceeds from any sales under this prospectus supplement will be used as described under “Use of Proceeds” in this prospectus supplement. In connection with the sale of the common stock on our behalf, the Jefferies will be deemed to be “underwriter” within the meaning of the Securities Act and the compensation of Jefferies will be deemed to be underwriting commissions or discounts. We have also agreed to provide indemnification and contribution to Jefferies with respect to certain liabilities, including liabilities under the Securities Act or the Securities Exchange Act of 1934, as amended, or the Exchange Act. See “Plan of Distribution” on page S-7 of this prospectus supplement for additional information concerning the compensation to be paid to Jefferies.

[BooDog]

Clearing their debt obviously cost shareholders plenty!!!


Still, opportunity? I took a few here. 1.12/1.13.

[tigertiger88]

Last one out turn off the lights

[tigertiger88]

ouch may go below a dollar

[tigertiger88]

Took a huge loss on this one today
GLTA that remain

[joro44]

More lost shareholder value - more dilution.

[tigertiger88]

Getting a little luv

[tigertiger88]

buyout coming imo